Dealmaking in the behavioral health space is slow these days — there’s no arguing that. But there are still plenty of lessons to be learned from the deals that have been completed thus far in 2024. With less to look at, there’s more to see. With fewer deals, we can spend more time taking in […]
Neuronetics (Nasdaq: STIM), a provider of transcranial magnetic stimulation (TMS), has acquired competitor Greenbrook TMS. Neuronetics purchased all of Greenbrook’s outstanding common shares in an all-stock transaction. The deal comes months after Greenbrook was delisted from the Nasdaq Stock Market LLC. “Beyond the strategic benefits, we believe this acquisition will help create a more attractive […]
Toronto-based Greenbrook TMS Inc. (Nasdaq: GBNH) has been kicked off the Nasdaq Stock Market LLC. On Friday, the transcranial magnetic stimulation (TMS) and Spravato clinic provider announced it had received a final delisting notice from the stock market. The suspension is effective as of the opening of trading on Feb. 26. It’s unclear when shares […]
Greenbrook TMS Inc. (NASDAQ:GBNH) is set to acquire Transcranial Magnetic Stimulation (TMS) company Success TMS. As part of the deal Success’ owners will receive 11.9 million shares of Greenbrook’s stock, worth roughly $27.3 million. Greenbrook will pick up 45 active TMS centers as part of the acquisition, bringing its total footprint to 191 active TMS […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
